FROM PRESENT CHALLENGES TO FUTURE SUCCESSES
ENGAGE WITH VISIONARY LEADERS, POLICYMAKERS, AND
HEALTHCARE PIONEERS TO SHAPE THE FUTURE OF ONCOLOGY
ENGAGE WITH VISIONARY LEADERS, POLICYMAKERS, AND
HEALTHCARE PIONEERS TO SHAPE THE FUTURE OF ONCOLOGY
CONFERENCE AGENDA
| 07:30 - 07:45 | REGISTRATION WELCOME REMARKS | DR. NORA ALMANA |
|
BREAST CANCER SESSION
|
|---|
|
SESSION I:
TOPIC: BREAST CANCER
MODERATOR:
DR. HELAYL ALHRABI DR. TAGHREED ALHINDI DR. AMIRA ALDOSSARY DR. FOZAN ALDULAIJAN |
||
|---|---|---|
| 07:45 - 08:30 | CRYOABLATION / VAE: A MINIMALLY INVASIVE ALTERNATIVE FOR BREAST SURGERY, EG. FROST TRIAL | DR. AFNAN ALMUHANNA |
| 08:30 - 09:15 | HER2 IN BREAST CANCER FROM PATHOLOGIST PROSPECTIVE | DR. ASMA TULBA |
| 09:15 - 10:00 | TARGETED PROTEIN DEGRADATION: NAVIGATING THE NEW LANDSCAPE OF ORAL SERDS AND PI3K INHIBITORS IN ENDOCRINE-RESISTANT DISEASE | DR. OSAMA HALAWEH |
| 10:15 - 10:30 | NURSING PERSPECTIVE: PSYCHOLOGICAL BURDEN OF CANCER APPEARANCE CHANGES AND THE EMERGING ROLE OF COOLING CAPS | DR. FATHIA AL-SOMALY |
| 10:30 - 10:45 | PHARMACY TALK: ANTI-HER2 TOXICITIES | DR. SHAHEED HUMEED |
| 10:45 - 11:00 | DISCUSSION / COFFEE BREAK | |
|
SESSION II:
TOPIC: MDT
MODERATOR:
DR. JAMILA ALAZHARI DR. REEM ALBEESH DR. AHMED WABARI |
||
|---|---|---|
| 11:00 - 11:30 | A.) INSEMA / SOUND | DR. MOHAMMED DUHAILEB |
| B.) B-51 | DR. REEM UJAIMI | |
| C.) MCD AND BREAST CONSERVING SURGERY | DR. SARA ALAJMI | |
| 11:30 - 13:00 | PRAYER / LUNCH BREAK | |
|
COLORECTAL CANCER SESSION
|
|---|
|
SESSION I:
TOPIC: COLORECTAL CANCER
MODERATOR:
DR. FAHAD BIN SHAMSAH DR. ADNAN ALHIBSHEE DR. FAISAL ALRASHED |
||
|---|---|---|
| 13:00 - 13:15 | LIQUID BIOPSY IN GENERAL WITH A FOCUS CRC: WHERE DOES IT FIT. | DR. SAEED ALTURKI |
| 13:15 - 13:30 | ORGAN PRESERVING CRC OR LOCAL EXCISION | DR. SULAIMAN ALSHEMMARI |
| 13:30 - 13:45 | SURGERY FREE FRONTIER (WATCH AND WAIT EXCLUDING IMMUNOTHERAPY) | DR. SHANGIETEE |
| 13:45 - 14:00 | PHARMACY: PHARMACOGENOMICS TESTING IN CRC: PERSONALIZED THERAPY | DR. HANA ALSHAIKH |
| 14:00 - 14:15 | BREAK (DURING BREAK) SATELLITE: IMMUNOTHERAPY IN CRC SPONSORED BY: GSK | TBD |
|
SESSION II:
TOPIC: MDT
DR. AMIRA BALHARITH
DR. WALED ALSELWI DR. HASSAN ALNAIMI DR. MAJED ALOTHMAN |
||
|---|---|---|
| 14:15 - 14:45 | A) OLIGOMETASTATIC | DR. SULAIMAN ALSHEMMARI |
| B) RECURRENCE PELVIS | DR. SULAIMAN ALSHEMMARI | |
|
LUNG SESSION
|
|---|
|
SESSION I:
TOPIC: LUNG
MODERATOR:
DR. AHMAD WABARI DR. ESAM MURSHED DR. MAJED ALOTHMAN DR. MANAL ALNUAIMI |
||
|---|---|---|
| SATELLITE SYMPOSIUM: NACT / IMMUNE THERAPY IN LOCALLY ADVANCE LUNG CANCER SPONSORED BY: | TBD | |
| 14:45 - 15:00 | ADCS AND NEXT-GEN TKIS: OVERCOMING RESISTANCE IN EGFR AND HER2-MUTANT LUNG CANCER | DR. MOHAMMAD ALGHAMDI |
| 15:00 - 15:15 | THE PRECISION RESECTION: SEGMENTECTOMY AS THE NEW GOLD STANDARD FOR STAGE 1A | DR. ALAA ALGHAMDI |
| 15:15 - 15:30 | RADIATION ONCOLOGY IN LUNG | DR. SALEM ALSHEHRI |
| 15:30 - 15:45 | PATHOLOGY TALK PDL-1 | DR. NAJD ALSHAMLAN |
| 15:45 - 16:00 | ANTI-EGFR AND IMMUNE CHECK POINTS INHIBITORS TOXICITIES IN LUNG CANCER PATIENTS | DR. NORA ALKHUDAIR |
| Q&A | ||
| CLOSING AND NETWORKING | ||